Association of Self-Recognition of Hearing Loss With Hospitalizations in Older Adults in the United States. [PDF]
Bessen S +5 more
europepmc +1 more source
If horses had toes: demonstrating mirror self recognition at group level in Equus caballus. [PDF]
Baragli P +3 more
europepmc +1 more source
Movement Disorders in Aicardi–Goutières Syndrome and Response to Immunomodulation
ABSTRACT This study characterizes movement disorders and treatment responses in seven children with Aicardi–Goutières syndrome (AGS). We retrospectively evaluated motor phenotypes, neuroimaging, and interferon signatures in patients treated with baricitinib or anifrolumab. Spasticity affected all patients, while dystonia was present in 4/7.
Enrique Gonzalez Saez‐Diez +10 more
wiley +1 more source
Wild recognition: conducting the mark test for mirror self-recognition on wild baboons. [PDF]
Ahmad EA +6 more
europepmc +1 more source
Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin +11 more
wiley +1 more source
Functions of galectins as ‘self/non‐self’‐recognition and effector factors
G. Vasta +7 more
semanticscholar +1 more source
Self-perception and self-recognition of facial profiles in adolescents referred to orthodontic treatment. [PDF]
Blagec T +4 more
europepmc +1 more source
Dynamic chiral self-recognition in aromatic dimers of styrene oxide revealed by rotational spectroscopy. [PDF]
Domingos SR +4 more
europepmc +1 more source
ABSTRACT Just recently, successful chimeric antigen receptor (CAR) T cell therapy was reported in the first patient with refractory, anti‐diacylglycerol lipase alpha (DAGLA) antibody‐mediated autoimmune encephalitis, achieving partial clinical remission.
Dimitrios Mougiakakos +9 more
wiley +1 more source
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi +5 more
wiley +1 more source

